Ucb Sa Stock Net Income
| UNC Stock | EUR 268.20 6.20 2.37% |
As of the 4th of February, UCB SA owns the Standard Deviation of 2.02, market risk adjusted performance of 4.92, and Mean Deviation of 1.36. Compared to fundamental indicators, the technical analysis model makes it possible for you to check helpful technical drivers of UCB SA, as well as the relationship between them. Please validate UCB SA information ratio, value at risk, and the relationship between the standard deviation and treynor ratio to decide if UCB SA is priced fairly, providing market reflects its prevailing price of 268.2 per share.
UCB SA's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing UCB SA's valuation are provided below:UCB SA does not today have any fundamental measures for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. UCB |
UCB SA 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to UCB SA's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of UCB SA.
| 11/06/2025 |
| 02/04/2026 |
If you would invest 0.00 in UCB SA on November 6, 2025 and sell it all today you would earn a total of 0.00 from holding UCB SA or generate 0.0% return on investment in UCB SA over 90 days. UCB SA is related to or competes with TERADATA, Wizz Air, Ryanair Holdings, INFORMATION SVC, RYANAIR HLDGS, Hyrican Informationssyst, and DATAGROUP. UCB SA, a biopharmaceutical company, develops therapies and solutions for people with neurology and immunology diseases More
UCB SA Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure UCB SA's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess UCB SA upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 1.54 | |||
| Information Ratio | 0.1444 | |||
| Maximum Drawdown | 11.17 | |||
| Value At Risk | (2.74) | |||
| Potential Upside | 4.3 |
UCB SA Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for UCB SA's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as UCB SA's standard deviation. In reality, there are many statistical measures that can use UCB SA historical prices to predict the future UCB SA's volatility.| Risk Adjusted Performance | 0.136 | |||
| Jensen Alpha | 0.3431 | |||
| Total Risk Alpha | 0.1969 | |||
| Sortino Ratio | 0.1899 | |||
| Treynor Ratio | 4.91 |
UCB SA February 4, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.136 | |||
| Market Risk Adjusted Performance | 4.92 | |||
| Mean Deviation | 1.36 | |||
| Semi Deviation | 1.15 | |||
| Downside Deviation | 1.54 | |||
| Coefficient Of Variation | 567.28 | |||
| Standard Deviation | 2.02 | |||
| Variance | 4.1 | |||
| Information Ratio | 0.1444 | |||
| Jensen Alpha | 0.3431 | |||
| Total Risk Alpha | 0.1969 | |||
| Sortino Ratio | 0.1899 | |||
| Treynor Ratio | 4.91 | |||
| Maximum Drawdown | 11.17 | |||
| Value At Risk | (2.74) | |||
| Potential Upside | 4.3 | |||
| Downside Variance | 2.37 | |||
| Semi Variance | 1.32 | |||
| Expected Short fall | (1.53) | |||
| Skewness | 1.45 | |||
| Kurtosis | 4.17 |
UCB SA Backtested Returns
UCB SA appears to be very steady, given 3 months investment horizon. UCB SA retains Efficiency (Sharpe Ratio) of 0.18, which indicates the company had a 0.18 % return per unit of volatility over the last 3 months. We have found thirty technical indicators for UCB SA, which you can use to evaluate the volatility of the entity. Please review UCB SA's Standard Deviation of 2.02, mean deviation of 1.36, and Market Risk Adjusted Performance of 4.92 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, UCB SA holds a performance score of 13. The firm owns a Beta (Systematic Risk) of 0.0707, which indicates not very significant fluctuations relative to the market. As returns on the market increase, UCB SA's returns are expected to increase less than the market. However, during the bear market, the loss of holding UCB SA is expected to be smaller as well. Please check UCB SA's total risk alpha, value at risk, and the relationship between the standard deviation and treynor ratio , to make a quick decision on whether UCB SA's current price history will revert.
Auto-correlation | 0.69 |
Good predictability
UCB SA has good predictability. Overlapping area represents the amount of predictability between UCB SA time series from 6th of November 2025 to 21st of December 2025 and 21st of December 2025 to 4th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of UCB SA price movement. The serial correlation of 0.69 indicates that around 69.0% of current UCB SA price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.69 | |
| Spearman Rank Test | 0.62 | |
| Residual Average | 0.0 | |
| Price Variance | 94.21 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, UCB SA reported net income of 1.06 B. This is 212.06% higher than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The net income for all Germany stocks is 86.52% lower than that of the firm.
UCB Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses UCB SA's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of UCB SA could also be used in its relative valuation, which is a method of valuing UCB SA by comparing valuation metrics of similar companies.UCB SA is currently under evaluation in net income category among its peers.
UCB Fundamentals
| Return On Equity | 0.14 | ||||
| Return On Asset | 0.0463 | ||||
| Profit Margin | 0.19 % | ||||
| Operating Margin | 0.20 % | ||||
| Current Valuation | 50.38 B | ||||
| Shares Outstanding | 190 M | ||||
| Shares Owned By Insiders | 36.27 % | ||||
| Shares Owned By Institutions | 40.80 % | ||||
| Price To Earning | 25.89 X | ||||
| Price To Book | 4.93 X | ||||
| Price To Sales | 7.27 X | ||||
| Revenue | 6.15 B | ||||
| Gross Profit | 5.02 B | ||||
| EBITDA | 1.85 B | ||||
| Net Income | 1.06 B | ||||
| Cash And Equivalents | 831 M | ||||
| Cash Per Share | 4.40 X | ||||
| Total Debt | 2 M | ||||
| Debt To Equity | 0.27 % | ||||
| Current Ratio | 1.23 X | ||||
| Book Value Per Share | 50.96 X | ||||
| Cash Flow From Operations | 1.24 B | ||||
| Earnings Per Share | 6.86 X | ||||
| Price To Earnings To Growth | 1.72 X | ||||
| Number Of Employees | 8.6 K | ||||
| Beta | 0.27 | ||||
| Market Capitalization | 49.78 B | ||||
| Total Asset | 17.35 B | ||||
| Retained Earnings | 7.39 B | ||||
| Working Capital | 1.26 B | ||||
| Annual Yield | 0.01 % | ||||
| Five Year Return | 1.62 % | ||||
| Net Asset | 17.35 B | ||||
| Last Dividend Paid | 1.39 |
About UCB SA Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze UCB SA's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of UCB SA using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of UCB SA based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Other Information on Investing in UCB Stock
UCB SA financial ratios help investors to determine whether UCB Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in UCB with respect to the benefits of owning UCB SA security.